Expression of connective tissue growth factor in human renal fibroblasts: Regulatory roles of RhoA and cAMP

Journal of the American Society of Nephrology

Volumn 12, Issue 9, 2001, Pages 1853-1861

  Heusinger Ribeiro, J ^a   Eberlein, M ^a   Wahab, N A ^a   Goppelt Struebe, M ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; CLOSTRIDIUM DIFFICILE TOXIN B; CONNECTIVE TISSUE GROWTH FACTOR; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYTOCHALASIN D; EXOTOXIN; LYSOPHOSPHATIDIC ACID; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PERTUSSIS TOXIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ACTIN FILAMENT; ARTICLE; CONTROLLED STUDY; FIBROBLAST; HUMAN; HUMAN CELL; KIDNEY CELL; METABOLIC REGULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION;

EID: 0034870254     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Connective tissue growth factor: A cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10
2. Connective tissue growth factor: A mediator of TGF-β action on fibroblasts
3. Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair
4. A novel transforming growth factor β response element controls the expression of the connective tissue growth factor gene
5. Transforming growth factor β induces anchorage-independent growth of NRK fibroblasts via a connective tissue growth factor-dependent signaling pathway
6. CTGF modulates cell cycle progression in cAMP-arrested NRK fibroblasts
7. Connective tissue growth factor mediates transforming growth factor β-induced collagen synthesis: Down-regulation by cAMP
8. Connective tissue growth factor gene expression in tissue sections from localized scleroderma, keloid, and other fibrotic skin disorders
9. Human connective tissue growth factor is expressed in advanced atherosclerotic lesions
10. Connective tissue growth factor: A novel regulator of mucosal repair and fibrosis in inflammatory bowel disease?
11. Expression of connective tissue growth factor in human renal fibrosis
12. Regulation of connective tissue growth factor activity in cultured rat mesangial cells and its expression in experimental diabetic glomerulosclerosis
13. Suppression subtractive hybridization identifies high glucose levels as a stimulus for expression of connective tissue growth factor and other genes in human mesangial cells
14. Prevention of progression of renal fibrosis: How far are we?
15. Progressive renal disease: Fibroblasts, extracellular matrix, and integrins
16. Factor VIIa and thrombin induce the expression of Cyr61 and connective tissue growth factor, extracellular matrix signaling proteins that could act as possible downstream mediators in factor VIIa tissue factor-induced signal transduction
17. Des-Arg(10)-kallidin engagement of the B1 receptor stimulates type I collagen synthesis via stabilization of connective tissue growth factor mRNA
18. Induction of connective tissue growth factor by activation of heptahelical receptors: Modulation by Rho proteins and the actin cytoskeleton
19. Inhibition of TGF-β-stimulated CTGF gene expression and anchorage-independent growth by cAMP identifies a CTGF-dependent restriction point in the cell cycle
20. The bioactive phospholipid lysophosphatidic acid is released from activated platelets
21. Diversity of cellular receptors and functions for the lysophospholipid growth factors lysophosphatidic acid and sphingosine 1-phosphate
22. Human renal fibroblast cell lines (tFKIF and tNKF) are new tools to investigate pathophysiologic mechanisms of renal interstitial fibrosis
23. The N-terminal part of the enzyme component (C2I) of the binary Clostridium botulinum C2 toxin interacts with the binding component C2II and functions as a carrier system for a Rho ADP-ribosylating C3-like fusion toxin
24. Signal transduction pathways responsible for serotonin-mediated prostaglandin G/H synthase expression in rat mesangial cells
25. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
26. Recombinant human G protein-coupled lysophosphatidic acid receptors mediate intracellular calcium mobilization
27. Lysophosphatidic acid-mediated signal transduction pathways involved in the induction of the early response genes prostaglandin G/H synthase-2 and Egr-1
28. Signaling to Rho GTPases
29. The small GTPase Rho: Cellular functions and signal transduction
30. Glucosylation of Rho proteins by Clostridium difficile toxin B
31. Rho, Rac, and Cdc42 GTPases regulate the assembly of multi-molecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia
32. Effectors for the Rho GTPases
33. Regulation of actin microfilament integrity in living non muscle cells by the cAMP-dependent protein kinase and the myosin light chain kinase
34. Characterization of Sp-5,6-dichloro-1-β-D-ribofuranosylbenzimidazole-3′,5′- monophosphorothioate (Sp-5,6-DCl-cBiMPS) as a potent and specific activator of cyclic-AMP-dependent protein kinase in cell extracts and intact cells
35. Signalling properties of lysophosphatidic acid in primary human skin fibroblasts: Role of pertussis toxin-sensitive GTP-binding proteins
36. Activation of RhoA by lysophosphatidic acid and Gα 12/13 subunits in neuronal cells: Induction of neurite retraction
37. Bacterial toxins that target Rho proteins
38. Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase)
39. Molecular dissection of the Rho-associated protein kinase (p160ROCK)-regulated neurite remodeling in neuroblastoma NIE-115 cells
40. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing
41. v-Src induction of the TIS 10/PGS2 prostaglandin synthase gene is mediated by an ATF/CRE transcription response element
42. Modulation of prostaglandin G/H synthase expression in mesangial cells transfected by pp60c-src proto-oncogene
43. Signaling pathways mediating induction of early response genes prostaglandin G/H synthase-2 and egr-1 by serotonin via 5-HT2a receptors
44. Transcriptional regulation of prostaglandin synthase 2 gene expression by platelet-derived growth factor and serum
45. Prostaglandin receptors in the kidney: A new route for intervention?
46. cAMP-induced morphological changes are counteracted by the activated RhoA small GTPase and the Rho kinase ROKα
47. Lysophosphatidic acid-induced neurite retraction in PC12 cells: Neurite-protective effects of cyclic AMP signaling
48. Regulation of astrocyte morphology by RhoA and lysophosphatidic acid
49. Protein kinase A phosphorylation of RhoA mediates the morphological and functional effects of cyclic AMP in cytotoxic lymphocytes
50. RhoA function in lamellae formation and migration is regulated by the α6β4 integrin and cAMP metabolism
51. Regulation of actin organisation by TGF-β in H-ras-transformed fibroblasts
52. Regulation of the mevalonate pathway